Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003646
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Stage IV Melanoma
Stage III Melanoma
Recurrent Melanoma
Interventions
DRUG:
allovectin-7
Sponsor
Vical